Binh Dinh Pharmaceutical and Medical Equipment JSC Capital Reinvestment Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC capital reinvestment ratio. Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Capital Reinvestment Ratio of 0.63x as of December 2025, meaning it reinvests 1% of its operating cash flow (₫213.49 Billion) in capital expenditures (₫135.54 Billion). See Binh Dinh Pharmaceutical and Medical Equ (DBD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Capital reinvestment ratio of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. This chart tracks Binh Dinh Pharmaceutical and Medical Equipment JSC's Capital Reinvestment Ratio across 6 annual periods. See financial flexibility index of Binh Dinh Pharmaceutical and Medical Equ to measure the company's free cash flow as a share of total liabilities.
Binh Dinh Pharmaceutical and Medical Equipment JSC Capital Reinvestment Ratio by Year (2020–2025)
Binh Dinh Pharmaceutical and Medical Equipment JSC capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see DBD cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | ₫615.19 Billion | ₫408.57 Billion | ▲ +18.2% |
| 2024 | 0.56x | ₫264.73 Billion | ₫148.75 Billion | ▲ +23.6% |
| 2023 | 0.45x | ₫293.99 Billion | ₫133.69 Billion | ▼ -9.4% |
| 2022 | 0.50x | ₫165.01 Billion | ₫82.83 Billion | ▲ +8.0% |
| 2021 | 0.46x | ₫117.57 Billion | ₫54.64 Billion | ▲ +65.6% |
| 2020 | 0.28x | ₫212.91 Billion | ₫59.73 Billion | — |